CoreCap Advisors’s iRadimed IRMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-60
Closed -$2K 1288
2022
Q2
$2K Buy
+60
New +$2.15K ﹤0.01% 1874
2022
Q1
Sell
-60
Closed -$3K 1289
2021
Q4
$3K Buy
+60
New +$2.42K ﹤0.01% 1876

Other funds holding IRMD

CoreCap Advisors's IRMD Position: Q3 2022 in Review

CoreCap Advisors sold out of iRadimed (IRMD) in Q3 2022, closing a stake of 60 shares — an estimated $2K sold.

CoreCap Advisors first reported a position in IRMD in Q4 2021 and held it in 2 quarters. The position peaked at $3K in Q4 2021. 86 funds tracked by Wall St. Rank hold IRMD as of Q3 2022.

  • CoreCap Advisors reported no remaining iRadimed position as of Q3 2022 after selling out during the quarter.
  • CoreCap Advisors sold 60 iRadimed shares in Q3 2022, an estimated $2K.
  • CoreCap Advisors first reported a position in iRadimed in Q4 2021 and held it in 2 quarters.
  • CoreCap Advisors's iRadimed position peaked at $3K in Q4 2021.
  • 86 funds tracked by Wall St. Rank held iRadimed as of Q3 2022.

Based on CoreCap Advisors's 13F filing for Q3 2022, filed 10 Feb 2023.